Inshirah Sgayer: Metformin’s Role in Enhancing Maternal Glycemic Control
Inshirah Sgayer, Consultant Obstetrician at Galilee Medical Center, shared a post by JAMA Network Open on LinkedIn about a paper published in JAMA Network Open:
“Proud to be part of this important multicenter collaboration published in JAMA Network.
Metformin after antenatal betamethasone improved maternal glycemic control and reduced neonatal hypoglycemia.
Read the full article below.”
Quoting JAMA Network Open‘s post, adding:
“RCT: Metformin after antenatal betamethasone improved maternal glycemic control and reduced preterm neonatal hypoglycemia, indicating a safe and effective preventive approach.”
Title: Metformin, Maternal Glycemic Control, and Neonatal Hypoglycemia After Antenatal Steroids
Authors: Enav Yefet, Manal Massalha, Gil Talmon, Aminet Labay, Marian Matanis, Erez Sleman, Rima Nassra, Maya Frank Wolf, Inshirah Sgayer, Lior Lowenstein, Zohar Nachum
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Jan 28, 2026, 16:59Unlocking the Potential of Menstrual Blood in Health Testing – Global Women’s Health Innovation Conclave
-
Jan 28, 2026, 16:57New Insights on Oocyte Yield in Endometriosis and PCOM – RBMO
-
Jan 28, 2026, 16:51Transform Your Expertise with ESHRE eCampus Learning – ESHRE
-
Jan 28, 2026, 16:46Accelerate Your Growth at the AP3G National Meeting – ASRM
-
Jan 28, 2026, 16:43Debojit Saha: Unraveling Chromosomal Errors in Aging Human Eggs
-
Jan 28, 2026, 16:38Silvia Vannuccini: RBMO Highlights Key Insights on Adenomyosis Awareness
-
Jan 28, 2026, 16:32Maximilian Attwood: Challenging Medical Misogyny in Endometriosis Research
-
Jan 28, 2026, 16:29Ioakeim Sapantzoglou: New Perspectives on Fetal Growth Restriction and Genetic Testing
-
Jan 28, 2026, 16:26Enhancing Pre-Eclampsia Prediction with Doppler Indices – ISUOG